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Introduction
Diabetic ketoacidosis (DKA) in children is a serious acute
complication of diabetes mellitus and continues to be an
important cause of morbidity and mortality. Treatment of
children with DKA is a complex blend of emergency therapy
and underlying disease management (1). Immediate 
but cautious fluid therapy is an essential component in the
management of patients with DKA. The European Society
for Paediatric Endocrinology (ESPE) and other international
consensus recommendations have emphasized the 
importance of  appropriate sodium (Na) concentration in the
rehydration solutions used in treatment of DKA (2,3,4,5).
Initially, 0.9% isotonic salt solution ([Na]= 154 mEq/L) has
been considered the most suitable parenteral solution to 
initiate rehydration for the first hour or in the first 4 hours,
depending on different authors, and thereafter is switched
to a solution of lower tonicity  (≥0.45% saline solution;
([Na]≥77 mEq/L) until complete rehydration (2,3,4,5).
However, there continues to be a debate about the amount
of intravenous (IV) fluid to be given, the speed of delivery of
fluid, and the type of fluid to be used. Because a 0.45%
saline solution is not available in Turkey, treatment of DKA
patients is initiated with 0.9% Na saline and continued by a
mixture of 5% dextrose and 0.9% Na saline. In the past, a
solution with a Na concentration of 75 mEq/L has been
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Objective: The management of children with diabetic ketoacidosis
(DKA) continues to be a controversial issue with regard to amount of
intravenous fluid to be given, rate of delivery of fluid, and type of fluid
to be used. We aimed to analyze the results obtained by administration
of rehydration fluids of  two different sodium (Na) concentrations (75
mEq/L vs. 100 mEq/L ) in the treatment of children with DKA.  
Methods: Thirty-two children with DKA were assessed for efficacy and
safety of fluid treatment. After an initial rehydration time, intravenous
fluids were switched to a 5% dextrose solution with a Na content of 75
mEq/L (Group I, n=19) or 100 mEq/L (Group II, n=13). Venous 
blood samples were collected from all subjects at diagnosis and at the
4th,  8th, 16th and  24th hours of treatment.
Results: Changes in blood glucose levels did not differ significantly
between the two  groups at the 4th,  8th, 16th and  24th hours of the 
follow-up. Nadir effective plasma osmolality (Peff osm) and Peff osm levels
also did not show statistically significant differences. Plasma sodium
(PNa) level did not drop lower than the level at diagnosis in both groups.
The changes in PNa concentrations in the two groups were not 
statistically significant at diagnosis or in follow-up samples (p=0.74).
pH, anion gap, pCO2 and HCO3 levels were also similar in Group I and
Group II. The duration of a pH level of <7.3 was shorter in Group II,   but
this was not statistically significant (p=0.65). None of the patients
enrolled in this study developed cerebral edema.   
Conclusion: The efficacy and safety of rehydration fluids with Na
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developed low plasma sodium levels (PNa) (corrected plasma
Na <130 mEq/L) on the 8th hour of treatment with this kind
of approach. Considering that this treatment regimen might
be a risk factor for development of cerebral edema (CE), we
began to use a solution with a Na concentration of 100
mEq/L in the treatment  of our DKA patients. 
In this study, we aimed to analyze the influence of 
two solutions with different Na concentrations in the 
rehydration of children with DKA. 
Material and Methods 
Patients who received an IV solution with a Na 
concentration of 75 mEq/L constituted Group I. This group
consisted of patients who were treated before year 2006.
Patients who received a solution with a Na concentration of
100 mEq/L constituted Group II.  All data including age, sex,
and new-onset diabetes were retrospectively collected
from patient records. The study was approved by the local
Ethics Committee.
This study included patients younger than 18 years of
age who were admitted to the pediatric intensive care unit
from 2002 to 2009. DKA was defined as having a glycemia
>200 mg/dL (11.4 mmol/L), a venous pH <7.30 or a plasma
bicarbonate level <15 mmol/L, and  ketonuria (2). Effective
plasma osmolality (Peff osm) was calculated as 2 x PNa+
PGlucose (plasma glucose) in mmol/L (6). PNa was corrected
for hyperglycemia using the method of Katz (7), whereby
corrected plasma sodium (PNacorr) (mmol/L)=actual Na+
[(serum glucose mmol/L - 5.6)/5.6] x 1.6. Definition of 
cerebral edema (CE) was made according to the criteria
defined by Edge et al (1). 
In both groups, initial rehydration was performed with
isotonic solutions in the first hour of treatment. The total
volume to be given was calculated assuming a 10% deficit
plus maintenance fluid. Amounts of fluids used in the 
initial resuscitation were subtracted from the total volume
calculated for 48 hours and the infusion rate was adjusted
accordingly. After initial rehydration, IV fluids were
switched to solutions containing 5% dextrose and [Na+] 75
mEq/L (Group I) or [Na+] 100 mEq/L (Group II). The only
source of Na used in our patients was Na chloride (NaCl).
The patients in Group I had received IV fluids with a Na
concentration of 75 mEq/L (1/2 isotonic NaCl plus 1/2 5%
dextrose) and those in Group II received IV fluids with a Na
concentration of 100 mEq/L (2/3 isotonic NaCl plus 1/3 5%
dextrose). During rehydration, the potassium concentration
of the IV fluids was adjusted as 40 mEq/L. The patients
were started on oral intake and subcutaneous insulin as
soon as the acidosis was resolved, serum Na level became
stable, and vomiting had stopped. After transition to oral
intake, the amount of oral fluid was subtracted from the
ongoing IV fluid treatment.
Data on age, sex, date of onset and duration of diabetes
at the time of diagnosis were recorded. Data pertaining to
the same patient in different DKA episodes were recorded
separately. After admission, blood glucose was measured
at hourly intervals. Samples of venous blood for blood
gases and electrolytes were taken at admission and at  the
4th, 8th, 16th and 24th hours after admission. 
The Mann-Whitney U test was used to compare the
clinical characteristics and laboratory values between the
two groups. ANOVA test was used for variance analysis
between groups. A p-value below 0.05 was accepted as
significant.
Results
A total of 32 children who received DKA treatment were
enrolled in the study. Twenty-six of these patients had 
new-onset diabetes. Group I included 19 patients and 13
patients were in Group II. None of the patients enrolled in
this study developed CE. Clinical characteristics and 
biochemical data for the two groups at the time of 
admission are given in Table 1.
The courses of glycemia and effective osmolality in our
patients are shown in Figure 1 and Figure 2. Blood glucose
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Table 1. Clinical and biochemical findings in the two groups at the time of
admission
Group I (n=19) Group II (n=13) p-value   
Age (years) 8.7±4.1 9.5±4  0.579
Sex (female/male) 11/8 4/9 0.166
PGlucose  (mg/dL) 533.7±246.4 599.7±241.3 0.27
pH 7.17±0.15 7.18±0.13 0.73
HCO3 (mEq/L) 6.93±3.82 6.61±3.99 0.81
pCO2 17±6.3 15.4±5.3 0.46
Anion gap 30.2±6.7 32.1±9.9 0.79
Peff osm (mOsm/L ) 293.2±9.4 293.4±12.4 0.80
PNa (mOsm/L) 132.2±7.4 130.5±5.5 0.89
PNacorr (mOsm/L) 138.9±4.7 138.2±5.5 0.74
Hct  (%)                                   42.1±4.3 42.1±3.6 0.96
Leukocyte   (mm3)                  20.3±11.1 20.6±13.6   0.82
P: plasma, Peff osm: effective plasma osmolality, PNa: plasma sodium,  
PNacorr: corrected plasma sodiumlevels after one hour of rehydration  were not statistically
different between groups (424.1±223.3 mg/dL in Group I
and 424±96 mg/dL in Group II) (p=0.236). The most 
significant decrease in blood glucose was noted at the 4th hour
of treatment in both groups and the proportions of change (in
percentages) in Group I and Group II were as  44.8±14% and
50.4±15%, respectively. Time at which  nadir blood glucose
level was reached was the 8th hour in Group I and the 16th
hour in Group II. Proportion of change (in percentages) in blood
glucose levels did not differ significantly between the groups
at 4th,  8th, 16th and  24th hours.
Duration of insulin administration by IV infusion showed
a significant difference between the groups, and was 5 
(2-62) hours in Group I and 23 (2-74) hours in Group II
(p=0.018). 
The median transition time to oral intake in Group I  was
8 (4-62) hours. This period  was shorter as compared to
Group II [23 (3-74) hours] (p=0.033).
The Peff osm dropped during the first 8 hours of 
treatment in Group I, whereas in Group II, such fall occurred
at the 16th hour of therapy . Nadir Peff osm level was 
similar in Group I and Group II (Figure 2). The difference in
Peff osm between the two groups did not show statistical
significance during follow-up (p=0.80). 
The course of natremia in our patients is shown in Figure
3. The PNa level did not drop lower than the level at diagnosis
in either group. Mean±SD of PNa levels at diagnosis and 
during follow-up are shown in Table 2. The difference in PNa
between Group I and Group II was not statistically significant
at either the diagnosis or the 4th, 8th, 16th and 24th hours after
diagnosis (p=0.35). The rate of patients with PNa
concentrations lower than 135 mmol/L was similar in both
groups at the 4th (46.2%; 38.5%), 8th (40%; 53.8%), 16th
(53.8%; 38.5%) and 24th (0%) hours after diagnosis (p>0.05).
A PNa concentration higher than 145 mmol/L was detected in
only one patient of each group at the 24th hour after diagnosis
(p>0.05). The course of PNacorr in our patients is shown in
Figure 4. The difference between the groups regarding PNacorr
was not statistically significant at diagnosis and during 
follow-up (p=0.74) (Table 2). The ratio of patients with a PNacorr
concentration lower than  135 mmol/L was also similar in both
groups (p>0.05).
The course of serum potassium levels in our patients is
shown in Table 2. There was no hypokalemia either in the
beginning or during the follow-up in either group.  pH, anion
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Figure 1. Time courses for PGlucose from the start of therapy up to 24
hours of therapy 
PGlucose: mg/dL
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Table 2. The PNa, PNacorr, K+, pH, HCO3, pCO2, anion gap in the two groups at diagnosis and at the 4th, 8th, 16th and 24th hour after diagnosis                        
GROUP I GROUP II
Time Diagnosis 4th hour 8th hour 16th hour 24th hour Diagnosis 4th hour 8th hour 16th hour 24th hour p-value
PNa (mEq/L) 132.2±7.4 136.0±5.4 134.2±4.2 134.5±2.5 140.1±2.0 130.5±5.5 135.6±4.1 136.0±5.7 134.9±4.1 141.1±4.1 0.4
PNacorr (mEq/L) 138.9±4.7 139.2±4.7 137.1±4.3 137.4±2.6 137.8±2.1 138.2±5.5 138.6±5 138.6±5.6 137.6±3.9 138.4±4.0 0.7
K+ (mEq/L) 4.4±0.4 4.2±0.4 4.2±0.3 4.1±0.4 3.9±0.4 4.7±0.4 4.4±0.4 4.2±0.4 40±0.6 4.1±0.5 0.5
pH 7.1±0.2 7.2±0.1 7.24±0.1 7.3±1.0 7.4±1.0 7.2±0.1 7.2±0.1 7.3±0.1 7.3±0.8 7.4±0.8 0.1
HCO3 (mEq/L) 5.3±3.7 6.9±4.4 8.4±4.0 10.9±4.6 14.8±6.8 6.6±4.2 8.1±5.3 10.1±4.1 11.2±3.9 15.0±5.0 0.9
pCO2 14.3±5.2 15.6±6.0 17.8±6.0 21.0±5.5 23.2±6.5 15.2±5.3 15.8±6.4 18.6±6.6 20.6±5.1 24.4±6.4 0.8
Anion gap 30.6±3.6 25.7±3.9 24.0±4.2 20.5±4.4 20.1±3.7 33.4±10.8 24.8±5.7 21.9±3.7 18.9±4 18±3.9 0.8
PNa: plasma sodium,  PNacorr: corrected plasma sodium
Figure 2. Time courses for Peff osm from the start of therapy up to 24
hours of therapy 
Peff osm: mOsm/kgH20
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)gap, pCO2 and HCO3 levels were also similar between
Group I and Group II at diagnosis and at  follow-up (Table 2).
Anion gap dropped below 20 mEq/L at the 16th hour in both
groups. The duration of a low pH (>7.3) in Group II 
was shorter than in Group I, but this was not statistically
significant (13.23±10.11 hours in Group II, 20.47±21.76
hours in Group I) (p=0.65). 
Discussion 
In most countries, treatment of DKA follows standard
protocols. In spite of meticulous treatment, a few children
develop complications, of which CE is the most dreaded. 
CE typically occurs 4-12 hours after the initiation of 
treatment for DKA, but may develop at any time during treat-
ment (8,9). The cause or causes of CE remain unknown. The
use of hypotonic fluids during resuscitation has been 
suggested as a cause (10,11), as have reductions in PNa
concentration (10,11,12) and rapid changes in plasma 
osmolality (13,14). In the light of current knowledge, 
hyponatremia should be avoided in children with DKA
(15,16). Rother et al (17) investigated whether rehydration of
young patients with DKA by use of a solution with 75 mmol/L
of Na would be associated with a decline in serum 
concentrations and they found that such rehydration did not
lead to decline in the uncorrected serum Na level. There is
still insufficient evidence correlating the Na concentration in
the rehydration solutions with the PNa levels during 
treatment (2,18). A tendency to increase Na levels during 
rehydration has been associated with a favorable outcome and
lesser incidence of CE. However, an important concern 
regarding the use of isotonic instead of hypotonic solutions for
rehydration is the risk of triggering hypernatremia (9,19,20). To
our knowledge, there is only one reported study comparing
hypotonic and isotonic solutions in DKA treatment. The results
of this study have suggested that the amount of Na in 
rehydration fluids is a relevant and independent factor that
favors the acquisition of a positive tendency of natremia (21).
These authors have stated that a higher PNa level is reached
with the use of an isotonic perfusate during rehydration than
that achieved with a perfusate with a Na content in a lower
range as recommended by international guidelines (2,3,4). 
In contrast to the results reported by Toledo et al (21),
in our study, the course of PNa, PNacorr and Peff osm at 
follow-up was not found to show any difference between
patients receiving rehydration solutions containing 75
mEq/L  and 100 mEq/L of Na. Also in contrast to the results
reported by these same authors,  higher Na levels or 
hypernatremia were not observed in the patients receiving
anisotonic solution. The ratio of patients with PNa and
PNacorr concentrations greater than 135 mEq/L during the
follow-up were similar and, PNa and PNacorr values did not
drop lower than diagnosis levels in both groups. 
In DKA, the hyperglycemia should be reduced gradually
at a rate of 50 to 100 mg/hr. Early switching to a dextrose-
containing solution, at a blood glucose level of about 250
mg/dL, helps to avoid rapid fluctuations in osmolality (22). In
our treatment protocol, to obtain a 0.45% saline solution,
we added 5% dextrose to the IV fluid after one-hour 
rehydration. We think that this prevents fluctuations in 
plasma osmolality and plays a major role in protecting from
CE. However, there is a need for further studies to clarify
the efficiency of this regimen in protecting from  CE. 
Another important aspect is the correlation between Na
administration and time needed to normalize acidosis.
Several studies have suggested that the use of fluids with
higher Na content would more rapidly correct acidosis (23).
The duration of pH<7.3 in Group II was shorter than that in
Group I but statistically not significant. In our study, the use
of an isotonic solution did not create a difference in anion
gap, HCO3 or pCO2 levels. However, longer intravenous
insulin duration and delay in passage to subcutaneous
insulin treatment might be due to variable individual
responses.
We conclude that the efficiency of rehydration fluids
with a Na concentration of 75 or 100 mmol/L in children
with DKA did not differ the course of PNa, PNacorr and 
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Figure 4. Time courses for PNacorr from the start of therapy up to 24
hours of therapy 
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Figure 3. Time courses for PNa from the start of therapy up to 24
hours of therapy 
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)Peff osm. This is the second trial that investigated the 
comparative efficiency of IV solutions with 75 and 100
mEq/L Na concentrations in the treatment of DKA. Thus,
although this study may serve to fill a gap in this subject, it
had some limitations. Firstly, we used a small sample size
and retrospective design and, secondly, we did not observe
any patient who developed CE in our sample. Therefore, we
believe that it will be logical to prospectively investigate 
the fluid concentrations used in the treatment of DKA
patients who develop CE and their effect, if any, on the 
development  of this condition. 
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